Cargando…
A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions
Prostate cancer metastasizes to bone in the majority of patients with advanced disease leading to painfully debilitating fractures, spinal compression and rapid decline. In addition, prostate cancer bone metastases often become resistant to standard therapies including androgen deprivation, radiatio...
Autores principales: | Raheem, Omer, Kulidjian, Anna A, Wu, Christina, Jeong, Young B, Yamaguchi, Tomonori, Smith, Kristen M, Goff, Daniel, Leu, Heather, Morris, Sheldon R, Cacalano, Nicholas A, Masuda, Koichi, Jamieson, Catriona HM, Kane, Christopher J, Jamieson, Christina AM |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3269442/ https://www.ncbi.nlm.nih.gov/pubmed/22035283 http://dx.doi.org/10.1186/1479-5876-9-185 |
Ejemplares similares
-
Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer
por: Hirata, Takeshi, et al.
Publicado: (2016) -
PCSD1, a new patient-derived model of bone metastatic prostate cancer, is castrate-resistant in the bone-niche
por: Godebu, Elana, et al.
Publicado: (2014) -
Hedgehog Signaling in Tumor Cells Facilitates Osteoblast-Enhanced Osteolytic Metastases
por: Das, Shamik, et al.
Publicado: (2012) -
Enhancement of osteoclastogenic activity in osteolytic prostate cancer cells by physical contact with osteoblasts
por: Shiirevnyamba, A, et al.
Publicado: (2011) -
Novel Dormancy Mechanism of Castration Resistance in Bone Metastatic Prostate Cancer Organoids
por: Lee, Sanghee, et al.
Publicado: (2022)